FDAnews Announces: 1 Week Until the 13th Annual FDA Inspections Summit, Oct. 23-25, 2018, Bethesda, MD

FALLS CHURCH, Va., Oct. 16, 2018 /PRNewswire-PRWeb/ -- 13th Annual FDA Inspections Summit
**Presented by FDAnews**
Oct. 23-25, 2018 ? Bethesda, MD
http://www.fdanews.com/fdainspectionssummit

The 13th Annual FDA Inspections Summit starts in one week.

So much has changed since last year's Inspections Summit that it sometimes feels difficult to keep up. The FDA is focused on any number of new topics: more generics, lower prices, opioids, internal restructuring, and much more. But one thing that hasn't changed is that they are still doing inspections and the regulated community is still making mistakes.

The FDA will always do inspections, and Commissioner Scott Gottlieb and the FDA have certainly not provided any hint that they are going to stop doing them any time soon.

Manufacturers can't afford to be caught off guard. Warning letters and 483 citations can cost manufacturers time, energy and money.

Come to Washington, DC, Oct. 23-25, for the 13th Annual FDA Inspections Summit, the must-attend conference of the regulatory year from FDAnews.

• Meet the FDAers whose actions spell fortune or failure; lawyers and consultants; industry hot-shots who've sussed out how to navigate a hyper-regulated milieu and still prosper.

o Confirmed FDA Speakers Include: David Glasgow, Deputy Director, Office of Bioresearch Monitoring Operations, OMPTO, ORA, FDA and Ellen Morrison, Associate Commissioner, OMPTO,ORA, FDA

• Drug, device and clinical separate tracks. There'll be panels galore aimed specifically at the particular issues that affect drug and device makers and clinical trials professionals
• Pre-Conference Drug, Device and Clinical Workshops filled with tips and tricks to help manufacturers sail through their next inspection.

Attend in person or live-stream the summit. The entire conference, including standout pre-conference workshops, is available in real time via livestreaming.

Reminder: The 13th Annual FDA Inspections Summit starts in one week.

Who Will Benefit:

•     Drugmakers
•     Devicemakers
•     Biologics firms
•     Clinical trials
•     Clinical research organizations
•     Diagnostics firms
•     Executive suite
•     Manufacturing/GMP
•     QA/QC
•     Regulatory affairs
•     Strategic planners
•     Legal counsel
•     Consultants

Conference Details
13th Annual FDA Inspections Summit
**Presented by FDAnews**
Oct. 23-25, 2018 ? Bethesda, MD
http://www.fdanews.com/fdainspectionssummit

Tuition:
In-Person Complete Summit: $1,997
Livestream Complete Summit: $1,497
Additional pricing options are available online.

Easy Ways to Register:
Online:     http://www.fdanews.com/fdainspectionssummit
By phone: 888-838-5578 or 703-538-7600

About FDAnews:
FDAnews is the premier provider of domestic and international regulatory, legislative, and business news and information for executives in industries regulated by the US FDA and the European Medicines Agency. Pharmaceutical and medical device professionals rely on FDAnews' print and electronic newsletters, books and conferences to stay in compliance with international standards and the FDA's complex and ever-changing regulations.

SOURCE FDANEWS